Prognosis of Hepatocellular Carcinoma: The BCLC Staging Classification
The DOI matches its Crossref record.
Abstract
The classifications of hepatocellular carcinoma (HCC) currently used are based on prognostic factors obtained from studies performed years ago when most tumors were diagnosed at advanced stages and the survival rates were substantially poor. Recent investigations have reviewed the survival of early tumors properly selected to receive radical therapies and the natural outcome of nonsurgical HCC patients. These data enable a new staging system to be proposed, the Barcelona Clinic Liver Cancer (BCLC) staging classification, that comprises four stages that select the best candidates for the best therapies currently available. Early stage (A) includes patients with asymptomatic early tumors suitable for radical therapies--resection, transplantation or percutaneous treatments. Intermediate stage (B) comprises patients with asymptomatic multinodular HCC. Advanced stage (C) includes patients with symptomatic tumors and/or an invasive tumoral pattern (vascular invasion/extrahepatic spread). Stage B and C patients may receive palliative treatments/new agents in the setting of phase II investigations or randomized controlled trials. End-stage disease (D) contain patients with extremely grim prognosis (Okuda stage III or PST 3-4) that should merely receive symptomatic treatment.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“The management of patients with HCC has improved markedly since the first BCLC classification was proposed in 1999143.”
From Adjuvant and neoadjuvant immunotherapies in hepatocellular carcinoma (2024) · cites this paper as [143]
Citations
Cites
Still being checked.
Cited by
Items 501–600 of 1,005
Kitai, S., Kudo, M., Minami, Y., Haji, S., Osaki, Y., Oka, H., Seki, T., Kasugai, H., Sasaki, Y., & Matsunaga, T. (2008) · Oncology · doi:10.1159/000173428 · Cited by 74
Zhang, J., Chen, Y., Zhang, B., Xie, X., Zhang, L., Ge, N.-L., Ren, Z., & Ye, S. (2011) · European Journal of Gastroenterology & Hepatology · doi:10.1097/meg.0b013e32834902dd · Cited by 81
Spreafico, C., Cascella, T., Facciorusso, A., Sposito, C., Lanocita, R., Morosi, C., Civelli, E. M., Vaiani, M., Bhoori, S., Pellegrinelli, A., et al. (2014) · CardioVascular and Interventional Radiology · doi:10.1007/s00270-014-0907-0 · Cited by 81
42,573 cases of hepatectomy in China: a multicenter retrospective investigation
Zhang, B., Zhang, B., Zhang, Z., Huang, Z., Chen, Y., Chen, M., Bie, P., Peng, B., Wu, L., Wang, Z., et al. (2018) · Science China Life Sciences · doi:10.1007/s11427-017-9259-9 · Cited by 81
Granito, A., Facciorusso, A., Sacco, R., Bartalena, L., Mosconi, C., Vittorio, U., Cappelli, A., Antonino, M., Modestino, F., Brandi, N., et al. (2021) · Journal of Personalized Medicine · doi:10.3390/jpm11101041 · Cited by 80
Transarterial Chemoembolization for Hepatocellular Carcinoma: Why, When, How?
Kotsifa, E., Vergadis, C., Vailas, M. G., Machairas, N., Kykalos, S., Damaskos, C., Garmpis, N., Lianos, G. D., & Schizas, D. (2022) · Journal of Personalized Medicine · doi:10.3390/jpm12030436 · Cited by 80
Dopazo, C., Søreide, K., Rangelova, E. B., Mieog, S., Carrión-Álvarez, L., Díaz-Nieto, R., Primavesi, F., & Stättner, S. (2023) · European Journal of Surgical Oncology · doi:10.1016/j.ejso.2023.107313 · Cited by 80
Imada, H., Kato, H., Yasuda, S., Yamada, S., Yanagi, T., Kishimoto, R., Kandatsu, S., Mizoe, J., Kamada, T., Yokosuka, O., et al. (2010) · Radiotherapy and Oncology · doi:10.1016/j.radonc.2010.05.019 · Cited by 80
Advances in non-surgical management of primary liver cancer
Chen, X., Liu, H.-P., Li, M., & Qiao, L. (2014) · World Journal of Gastroenterology · doi:10.3748/wjg.v20.i44.16630 · Cited by 80
14-3-3ε Overexpression Contributes to Epithelial-Mesenchymal Transition of Hepatocellular Carcinoma
Liu, T.-A., Jan, Y., Ko, B., Liang, S.-M., Chen, S.-C., Wang, J., Hsu, C., Wu, Y., & Liou, J. (2013) · PLoS ONE · doi:10.1371/journal.pone.0057968 · Cited by 80
Increasing Incidence of Hepatocellular Carcinoma in HIV-Infected Patients in Spain
Merchante, N., Merino, E., López-Aldeguer, J., Jover, F., Delgado‐Fernández, M., Galindo, M. J., Ortega, E., Rivero, A., Mínguez, C., Romero-Palacios, A., et al. (2012) · Clinical Infectious Diseases · doi:10.1093/cid/cis777 · Cited by 80
Liver (Including Intrahepatic Bile Ducts)
Greene, F. L., Ph.D., C.T.R., A. G. F., et al. (2006) · Springer eBooks · doi:10.1007/0-387-33126-3_14 · Cited by 80
Zhang, R., Shen, L., Zhao, L., Guan, Z., Chen, Q., & Li, W. (2018) · Diagnostic and Interventional Radiology · doi:10.5152/dir.2018.17528 · Cited by 80
Patel, D., Terrault, N. A., Yao, F. Y., Bass, N. M., & Ladabaum, U. (2005) · Clinical Gastroenterology and Hepatology · doi:10.1016/s1542-3565(04)00443-4 · Cited by 77
Hepatocellular Carcinoma: Novel Molecular Targets in Carcinogenesis for Future Therapies
Bertino, G., Demma, S., Ardiri, A., Proiti, M., Malaguarnera, G., Bertino, N., Malaguarnera, M., & Malaguarnera, M. (2014) · BioMed Research International · doi:10.1155/2014/203693 · Cited by 79
RetractedChronic Hepatitis B and Hepatocellular Carcinoma
McClune, A. C., & Tong, M. J. (2010) · Clinics in Liver Disease · doi:10.1016/j.cld.2010.05.009 · Cited by 79
Drug Therapy for Advanced-Stage Liver Cancer
Peck‐Radosavljevic, M. (2014) · Liver Cancer · doi:10.1159/000343868 · Cited by 79
Diagnostic and Therapeutic Delays in Patients With Hepatocellular Carcinoma
Rao, A., Rich, N. E., Marrero, J. A., Yopp, A. C., & Singal, A. G. (2021) · Journal of the National Comprehensive Cancer Network · doi:10.6004/jnccn.2020.7689 · Cited by 79
Cammà, C., Marco, V. D., Cabibbo, G., Latteri, F., Sandonato, L., PARISI, P., Enea, M., Attanasio, M., Galia, M., Alessi, N., et al. (2008) · Alimentary Pharmacology & Therapeutics · doi:10.1111/j.1365-2036.2008.03692.x · Cited by 79
Phase I Dose-Escalation Study of Proton Beam Therapy for Inoperable Hepatocellular Carcinoma
Kim, T. H., Park, J., Kim, Y.-J., Kim, B. H., Woo, S. M., Moon, S. H., Kim, S. S., Koh, Y. H., Lee, W. J., Park, S., et al. (1970) · Cancer Research and Treatment · doi:10.4143/crt.2013.218 · Cited by 79
Chen, C., Hu, F.-C., Huang, G., Lee, P., Tsang, Y.-M., Cheng, A., Chen, D., Wang, J., & Sheu, J. (2009) · European Journal of Cancer · doi:10.1016/j.ejca.2008.12.025 · Cited by 79
Quality-Improvement Guidelines for Hepatic Transarterial Chemoembolization
Basile, A., Carrafiello, G., Ierardi, A. M., Tsetis, D. K., & Brountzos, Ε. (2012) · CardioVascular and Interventional Radiology · doi:10.1007/s00270-012-0423-z · Cited by 79
Combined approach to hepatocellular carcinoma: a new treatment concept for nonresectable disease
Strebel, B. M., & Dufour, J. (2008) · Expert Review of Anticancer Therapy · doi:10.1586/14737140.8.11.1743 · Cited by 79
Transcription factor Late SV40 Factor (LSF) functions as an oncogene in hepatocellular carcinoma
Yoo, B. K., Emdad, L., Gredler, R., Fuller, C. E., Dumur, C. I., Jones, K. H., Jackson‐Cook, C. K., Su, Z.-Z., Chen, D., Saxena, U. H., et al. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1000374107 · Cited by 78
Park, J., Amarapurkar, D. N., Chao, Y., Chen, P., Geschwind, J. H., Goh, K., Han, K., Kudo, M., Lee, H. C., Lee, R., et al. (2012) · Liver International · doi:10.1111/liv.12083 · Cited by 78
Treatment Algorithms for Managing Hepatocellular Carcinoma
Saraswat, V. A., Pandey, G., & Shetty, S. (2014) · Journal of Clinical and Experimental Hepatology · doi:10.1016/j.jceh.2014.05.004 · Cited by 78
Delis, S., & Dervenis, C. (2008) · World Journal of Gastroenterology · doi:10.3748/wjg.14.3452 · Cited by 78
Hepatocellular carcinoma: Review of disease and tumor biomarkers
Kim, J. U., Shariff, M. I. F., Crossey, M. M. E., Gómez‐Romero, M., Holmes, E. C., Cox, I. J., Fye, H. K. S., Njie, R., & Taylor-Robinson, S. D. (2016) · World Journal of Hepatology · doi:10.4254/wjh.v8.i10.471 · Cited by 78
Chen, Z., Zhang, X., Wang, H., Chai, Z., Sun, J., Guo, W., Shi, J., & Cheng, S. (2019) · HPB · doi:10.1016/j.hpb.2019.02.003 · Cited by 78
Zhang, W., Hu, B., Han, J. S., Wang, Z., Ma, G., Ye, H., Yuan, J., Cao, J., Zhang, Z., Shi, J., et al. (2021) · Frontiers in Oncology · doi:10.3389/fonc.2021.747950 · Cited by 77
Reig, M., Forner, A., Avila, M. A., Ayuso, C., Mínguez, B., Varela, M., Bilbao, I., Bilbao, J. I., Burrel, M., Bustamante, J., et al. (2021) · Medicina Clínica · doi:10.1016/j.medcli.2020.09.022 · Cited by 77
Self-citationSu, C., Zhou, S., Zhang, L., Ren, S., Xu, J., Zhang, J., Lv, M., Zhang, J., & Zhou, C. (2010) · Medical Oncology · doi:10.1007/s12032-010-9553-9 · Cited by 77
Problem of hepatocellular carcinoma in West Africa
Ladep, N. G., Lesi, O. A., Mark, P., Lemoine, M., Onyekwere, C., Afihene, M., Crossey, M. M. E., & Taylor-Robinson, S. D. (2014) · World Journal of Hepatology · doi:10.4254/wjh.v6.i11.783 · Cited by 78
Prognostic factors in patients with advanced hepatocellular carcinoma treated with sorafenib
Pinter, M., Sieghart, W., Hucke, F., Graziadei, I., Vogel, W., Maieron, A., Königsberg, R., Weißmann, A.-C., Kornek, G. V., Matejka, J., et al. (2011) · Alimentary Pharmacology & Therapeutics · doi:10.1111/j.1365-2036.2011.04823.x · Cited by 77
Deng, Y., Pang, Q., Miao, R., Chen, W., Zhou, Y., Bi, J., Liu, S., Zhang, J., Qu, K., & Liu, C. (2016) · OncoTargets and Therapy · doi:10.2147/ott.s109736 · Cited by 77
Sarcopenia Predicts Reduced Survival in Patients with Hepatocellular Carcinoma at First Diagnosis
Begini, P., Gigante, E., Antonelli, G., Carbonetti, F., Iannicelli, E., Anania, G., Imperatrice, B., Pellicelli, A. M., Fave, G. D., & Marignani, M. (2016) · Annals of Hepatology · doi:10.5604/16652681.1226821 · Cited by 77
Bruix, J., SALA, M., & LLOVET, J. (2007) · Elsevier eBooks · doi:10.1016/b978-1-4160-3256-4.50084-3 · Cited by 77
Self-citationYang, F., Ma, L., Yang, Y., Liu, W., Zhao, J., Chen, X., Wang, M., Zhang, H., Cheng, S., Shen, F., et al. (2019) · Frontiers in Oncology · doi:10.3389/fonc.2019.00370 · Cited by 76
Nart, D., Yaman, B., Yılmaz, F., Zeytunlu, M., Karasu, Z. A., & Kılıç, M. (2010) · Liver Transplantation · doi:10.1002/lt.22028 · Cited by 76
Future perspectives in hepatocellular carcinoma
Wörns, M., & Galle, P. R. (2010) · Digestive and Liver Disease · doi:10.1016/s1590-8658(10)60521-x · Cited by 76
Liu, W., Ren, L., Wang, X., Wang, T., Zhang, N., Gao, Y., Luo, H. L., Navarro–Álvarez, N., & Tang, L. (2015) · Journal of Cancer Research and Clinical Oncology · doi:10.1007/s00432-015-1943-0 · Cited by 76
Prajapati, H. J., Dhanasekaran, R., El‐Rayes, B. F., Kauh, J. S. W., Maithel, S. K., Chen, Z., & Kim, H. S. (2013) · Journal of Vascular and Interventional Radiology · doi:10.1016/j.jvir.2012.11.026 · Cited by 76
Kumar, A., Acharya, S. K., Singh, S. P., Saraswat, V. A., Arora, A., Duseja, A. K., Goenka, M. K., Jain, D., Kar, P., Kumar, M., et al. (2014) · Journal of Clinical and Experimental Hepatology · doi:10.1016/j.jceh.2014.04.003 · Cited by 78
Canellas, R., Mehrkhani, F., Patiño, M., Kambadakone, A. R., & Sahani, D. V. (2016) · American Journal of Roentgenology · doi:10.2214/ajr.15.15928 · Cited by 76
Shiha, G. E.-S., Mousa, N., Soliman, R., Mikhail, N. N. H., Elbasiony, M. A., & Khattab, M. A. (2020) · Journal of Viral Hepatitis · doi:10.1111/jvh.13276 · Cited by 76
Hepatocellular Carcinoma: Prevention, Diagnosis, and Treatment
Feng, F., & Zhao, Y. (2024) · Medical Principles and Practice · doi:10.1159/000539349 · Cited by 76
Development of Hepatocellular Carcinoma in Autoimmune Hepatitis Patients: A Case Series
Wong, R. J., Gish, R. G., Frederick, R. T., Bzowej, N. H., & Frenette, C. T. (2010) · Digestive Diseases and Sciences · doi:10.1007/s10620-010-1444-6 · Cited by 75
Changchien, C., Chen, C., Yen, Y., Wang, J., Hu, T., Lee, C., Wang, C., Cheng, Y., Huang, Y.-J., Lin, C., et al. (2008) · Journal of Gastroenterology · doi:10.1007/s00535-007-2134-9 · Cited by 75
Pre-operative Microvascular Invasion Prediction Using Multi-parametric Liver MRI Radiomics
Nebbia, G., Zhang, Q., Arefan, D., Zhao, X., & Wu, S. (2020) · Journal of Imaging Informatics in Medicine · doi:10.1007/s10278-020-00353-x · Cited by 75
Use of chemotherapy to treat hepatocellular carcinoma
Hou, Z., Liu, J., Jin, Z., Qiu, G., Xie, Q., Mi, S., & Huang, J. (2022) · BioScience Trends · doi:10.5582/bst.2022.01044 · Cited by 75
Natural History of Hepatocellular Carcinoma and Current Treatment Options
Raoul, J. (2008) · Seminars in Nuclear Medicine · doi:10.1053/j.semnuclmed.2007.10.004 · Cited by 74
Waidmann, O., Köberle, V., Bettinger, D., Trojan, J., Zeuzem, S., Schultheiß, M., Kronenberger, B., & Piiper, A. (2013) · Journal of Hepatology · doi:10.1016/j.jhep.2013.06.008 · Cited by 74
Ang, S. F., Ng, E. S.-H., Li, H., Ong, Y.-H., Choo, S. P., Ngeow, J. Y. Y., Toh, H. C., Lim, K. H., Yap, H. Y., Tan, C., et al. (2015) · PLoS ONE · doi:10.1371/journal.pone.0118658 · Cited by 74
A study of circulating interleukin 10 in prognostication of unresectable hepatocellular carcinoma
Chan, S. L., Mo, F. K. F., Wong, S. C. C., Chan, C. M. L., Leung, L. K. S., Hui, E. P., Ma, B. B. Y., Chan, A. T. �., Mok, T. S. K., & Yeo, W. (2011) · Cancer · doi:10.1002/cncr.26726 · Cited by 74
Kim, K. M., Sinn, D. H., Jung, S., Gwak, G., Paik, Y., Choi, M. S., Lee, J. H., Koh, K. C., & Paik, S. W. (2016) · Liver International · doi:10.1111/liv.13107 · Cited by 74
Waung, J. A., Todd, J. F., Keane, M. G., & Pereira, S. P. (2016) · Endoscopy · doi:10.1055/s-0042-104650 · Cited by 74
Tumours and Tumour-like Lesions of the Liver
Ferrell, L. D., Kakar, S., Terracciano, L., & Wee, A. (2017) · Elsevier eBooks · doi:10.1016/b978-0-7020-6697-9.00013-3 · Cited by 74
Recent advances in medical management of hepatocellular carcinoma
Ikeda, K. (2018) · Hepatology Research · doi:10.1111/hepr.13259 · Cited by 75
Iwamoto, H., Suzuki, H., Shimose, S., Niizeki, T., Nakano, M., Shirono, T., Okamura, S., Noda, Y., Kamachi, N., Nakamura, T., et al. (2020) · Cancers · doi:10.3390/cancers12041010 · Cited by 75
Application of radiotherapy for hepatocellular carcinoma in current clinical practice guidelines
Rim, C. H., & Seong, J. (2016) · Radiation Oncology Journal · doi:10.3857/roj.2016.01970 · Cited by 73
Survival analysis of proposed BCLC ‐B subgroups in hepatocellular carcinoma patients
Weinmann, A., Koch, S., Sprinzl, M. F., Kloeckner, R., Schulze‐Bergkamen, H., Düber, C., Lang, H., Otto, G., Wörns, M., & Galle, P. R. (2014) · Liver International · doi:10.1111/liv.12696 · Cited by 73
Cucchetti, A., Vitale, A., Gaudio, M. D., Ravaioli, M., Ercolani, G., Cescon, M., Zanello, M., Morelli, M. C., Cillo, U., Grazi, G. L., et al. (2010) · American Journal of Transplantation · doi:10.1111/j.1600-6143.2009.02984.x · Cited by 73
Villanueva, A., Toffanin, S., & Llovet, J. M. (2008) · Current Opinion in Oncology · doi:10.1097/cco.0b013e328302c9e9 · Cited by 73
Self-citationGain of GRHL2 is associated with early recurrence of hepatocellular carcinoma
Tanaka, Y., Kanai, F., Tada, M., Tateishi, R., Sanada, M., Nannya, Y., Ohta, M., Asaoka, Y., Seto, M., Shiina, S., et al. (2008) · Journal of Hepatology · doi:10.1016/j.jhep.2008.06.019 · Cited by 73
Serenari, M., Zanello, M., Schadde, E., Toschi, E., Ratti, F., Gringeri, E., Masetti, M., Cillo, U., Aldrighetti, L. A., Jovine, E., et al. (2016) · HPB · doi:10.1016/j.hpb.2016.02.003 · Cited by 73
Systemic treatment of hepatocellular carcinoma: Past, present and future
Cidón, E. U. (2017) · World Journal of Hepatology · doi:10.4254/wjh.v9.i18.797 · Cited by 73
Cost-Utility Analysis of Imaging for Surveillance and Diagnosis of Hepatocellular Carcinoma
Lima, P. H., Fan, B., Bérubé, J., Cerny, M., Olivié, D., Giard, J., Beauchemin, C., & Tang, A. (2019) · American Journal of Roentgenology · doi:10.2214/ajr.18.20341 · Cited by 73
ALBI versus child-pugh in predicting outcome of patients with HCC: A systematic review
Peng, Y., Wei, Q., He, Y., Xie, Q., Liang, Y., Zhang, L., Xia, Y., Li, Y., Chen, W., Zhao, J., et al. (2020) · Expert Review of Gastroenterology & Hepatology · doi:10.1080/17474124.2020.1748010 · Cited by 73
Feng, D., Wang, M., Hu, J., Li, S., Zhao, S., Li, H., & Liu, L. (2020) · Annals of Translational Medicine · doi:10.21037/atm.2020.02.116 · Cited by 72
Transarterial Chemoembolization for Hepatocellular Carcinoma
Lau, W. Y., Yu, S. C. H., Lai, E. C. H., & Leung, T. W. H. (2005) · Journal of the American College of Surgeons · doi:10.1016/j.jamcollsurg.2005.06.263 · Cited by 72
van Malenstein, H., Gevaert, O., Libbrecht, L. J., Daemen, A., Allemeersch, J., Nevens, F., Cutsem, E. V., Cassiman, D. M., Moor, B. D., Verslype, C., et al. (2010) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-09-3274 · Cited by 72
Liver Cancer Working Group Report
Kudo, M., Han, K., Kokudo, N., Cheng, A., Choi, B. I., Furuse, J., Izumi, N., Park, J.-W., Poon, R. T. P., & Sakamoto, M. (2010) · Japanese Journal of Clinical Oncology · doi:10.1093/jjco/hyq123 · Cited by 72
Fassio, E., Díaz, S. V., Santa, C., Reig, M., Artola, Y. M., de Mattos, Â. A., Míguez, C., Galizzi, J., Zapata, R., Ridruejo, E., et al. (2010) · Annals of Hepatology · doi:10.1016/s1665-2681(19)31681-3 · Cited by 72
Gorodetski, B., Chapiro, J., Schernthaner, R. E., Durán, R., Lin, M., Lee, H., Lenis, D., Stuart, E. A., Nonyane, B. A. S., Pekurovsky, V., et al. (2016) · European Radiology · doi:10.1007/s00330-016-4445-9 · Cited by 72
Varghese, J., Kedarisetty, C. K., Venkataraman, J., Srinivasan, V., Thiruchunapalli, D., Uthappa, M. C., Ilankumaran, K., Govil, S., Reddy, M. S., & Rela, M. (2017) · Annals of Hepatology · doi:10.5604/16652681.1231585 · Cited by 72
Lencioni, R. A., Pina, C. D., & Bartolozzi, C. (2005) · Abdominal Imaging · doi:10.1007/s00261-004-0254-8 · Cited by 72
Critical evaluation of the different staging systems for hepatocellular carcinoma
Wildi, S. M., Pestalozzi, B. C., McCormack, L., & Clavien, P. (2004) · British journal of surgery · doi:10.1002/bjs.4554 · Cited by 72
The natural history of hepatocellular carcinoma
Romeo, R., & Colombo, M. (2002) · Toxicology · doi:10.1016/s0300-483x(02)00252-4 · Cited by 72
Lin, W., Xing, K., Fu, J., Ling, Y., Li, S., Yu, W.-S., Zhang, Y., Zhong, C., Wang, J., Chen, Z., et al. (2021) · JAMA Network Open · doi:10.1001/jamanetworkopen.2021.25055 · Cited by 71
Tang, W., Sun, G., Ji, G., Feng, T., Zhang, Q., Cao, H., Wu, W., Zhang, X., Liu, C., Liu, H.-Y., et al. (2023) · Journal for ImmunoTherapy of Cancer · doi:10.1136/jitc-2023-007030 · Cited by 71
Prognosis of Hepatocellular Carcinoma in Relation to Treatment Across BCLC Stages
D’Avola, D., Iñarrairaegui, M., Pardo, F., Rotellar, F., Marti, P., Bilbao, J. I., Martínez-Cuesta, A., Benito, A., Alegre, F., Mauleón, E., et al. (2011) · Annals of Surgical Oncology · doi:10.1245/s10434-011-1551-4 · Cited by 71
Jianyong, L., Lunan, Y., Wentao, W., Yong, Z., Li, B., Tianfu, W., Minqing, X., & Jiaying, Y. (2014) · Medicine · doi:10.1097/md.0000000000000180 · Cited by 71
Huo, T., Lin, H., Hsia, C., Wu, J., Lee, P.-C., Chi, C., & Lee, S. (2007) · The American Journal of Gastroenterology · doi:10.1111/j.1572-0241.2007.01370.x · Cited by 71
Screening for Cancer in Viral Hepatitis
Colombo, M. (2001) · Clinics in Liver Disease · doi:10.1016/s1089-3261(05)70156-2 · Cited by 71
Huang, Y., Wu, J., CHEN, S. ‐., Chen, C., Chiang, J., Huo, T.-I., Lee, P., Chang, F. ‐., & Lee, S. (2005) · Alimentary Pharmacology & Therapeutics · doi:10.1111/j.1365-2036.2006.02704.x · Cited by 71
Sustained virological response: A milestone in the treatment of chronic hepatitis C
Morisco, F., Granata, R., Stroffolini, T., Guarino, M., Donnarumma, L., Gaeta, L., Loperto, I., Gentile, I., Auriemma, F., & Caporaso, N. (2013) · World Journal of Gastroenterology · doi:10.3748/wjg.v19.i18.2793 · Cited by 71
Epidemiology and Survival of Hepatocellular Carcinoma in the Central Region of Thailand
Somboon, K., Siramolpiwat, S., & Vilaichone, R. (2014) · Asian Pacific Journal of Cancer Prevention · doi:10.7314/apjcp.2014.15.8.3567 · Cited by 71
Moore, A., Cohen‐Naftaly, M., Tobar, A., Kundel, Y., Benjaminov, O., Braun, M., Issachar, A., Mor, E., Sarfaty, M., Bragilovski, D., et al. (2017) · Radiation Oncology · doi:10.1186/s13014-017-0899-4 · Cited by 71
Moawad, A. W., Morshid, A. I., Khalaf, A., Elmohr, M. M., Hazle, J. D., Fuentes, D., Badawy, M., Kaseb, A. O., Hassan, M. M., Mahvash, A., et al. (2023) · Scientific Data · doi:10.1038/s41597-023-01928-3 · Cited by 71
Golgi protein-73: A biomarker for assessing cirrhosis and prognosis of liver disease patients
Gatselis, N., Tornai, T., Shums, Z., Zachou, K., Saitis, A., Gabeta, S., Albesa, R., Norman, G. L., Papp, M., & Dalekos, G. Ν. (2020) · World Journal of Gastroenterology · doi:10.3748/wjg.v26.i34.5130 · Cited by 70
Sarcopenia in hepatocellular carcinoma: Current knowledge and future directions
Perisetti, A., Goyal, H., Yendala, R., Chandan, S., Tharian, B., & Thandassery, R. B. (2022) · World Journal of Gastroenterology · doi:10.3748/wjg.v28.i4.432 · Cited by 70
Kokabi, N., Camacho, J. C., Xing, M., El‐Rayes, B. F., Spivey, J. R., Knechtle, S. J., & Kim, H. S. (2015) · Cancer · doi:10.1002/cncr.29275 · Cited by 70
Bhangoo, M. S., Karnani, D. R., Hein, P. N., Giap, H., Knowles, H. J., Issa, C., Steuterman, S., Pockros, P. J., & Frenette, C. T. (2015) · Europe PMC (PubMed Central) · doi:10.3978/j.issn.2078-6891.2015.056 · Cited by 70
Proneth, A., Zeman, F., Schlitt, H. J., & Schnitzbauer, A. A. (2014) · Annals of Surgical Oncology · doi:10.1245/s10434-014-3808-1 · Cited by 70
Leoni, S., Piscaglia, F., Serio, I., Terzi, E., Pettinari, I., Croci, L., Marinelli, S., Benevento, F., Golfieri, R., & Bolondi, L. (2014) · Digestive and Liver Disease · doi:10.1016/j.dld.2014.02.012 · Cited by 70
Role of the multidisciplinary team in the diagnosis and treatment of hepatocellular carcinoma
Gish, R. G., Lencioni, R. A., Bisceglie, A. M. D., Raoul, J., & Mazzaferro, V. (2012) · Expert Review of Gastroenterology & Hepatology · doi:10.1586/egh.11.105 · Cited by 70
den Winkel, M. O., Nagel, D., Julia, S., den Winkel, P. O., Lamerz, R., Zech, C. J., Straub, G., Nickel, T., Rentsch, M., Stieber, P., et al. (2012) · PLoS ONE · doi:10.1371/journal.pone.0045066 · Cited by 70
Surgical Treatment for Hepatocellular Carcinoma
Takayama, T. (2011) · Japanese Journal of Clinical Oncology · doi:10.1093/jjco/hyr016 · Cited by 70
Virus-induced hepatocellular carcinoma with special emphasis on HBV
Wang, M., Dong, X., & Ning, Q. (2017) · Hepatology International · doi:10.1007/s12072-016-9779-5 · Cited by 70
Hepatocellular carcinoma locoregional therapies: Outcomes and future horizons
Makary, M. S., Ramsell, S., Miller, E. D., Beal, E. W., & Dowell, J. D. (2021) · World Journal of Gastroenterology · doi:10.3748/wjg.v27.i43.7462 · Cited by 70
Metadata
- Authors
- Llovet, J., Brú, C., & Bruix, J.
- Affiliations
- Consorci Institut D'Investigacions Biomediques August Pi I Sunyer (ES)
- Venue
- Seminars in Liver Disease
- Publisher
- Georg Thieme Verlag KG
- Published
- 1999
- Volume
- 19
- Issue
- 03
- Pages
- 329-338
- ISSN
- 0272-8087 (ISSN-L)
- 1098-8971
- OpenAlex
- W2147172608
- Cited by
- 3,805
- References
- 0
- Citations by year
- 2026: 70 · 2025: 117 · 2024: 162 · 2023: 211 · 2022: 269 · 2021: 280 · 2020: 279 · 2019: 215 · 2018: 206 · 2017: 218 · 2016: 216 · 2015: 220 · 2014: 219 · 2013: 163 · 2012: 154
- FWCI
- 11.18
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Seminars in Liver Disease (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Hepatology › Hepatocellular Carcinoma Treatment and Prognosis
- Health Sciences › Medicine › Otorhinolaryngology › Head and Neck Cancer Studies
- Health Sciences › Medicine › Epidemiology › Hepatitis B Virus Studies
- Keywords
- hepatocellular carcinoma, prognosis, tumor staging, radical treatment, liver transplantation, hepatectomy, percutaneous treatment, vascular invasion, extrahepatic spread, palliative care, Okuda staging
- MeSH terms
- Carcinoma, Hepatocellular, Humans, Liver Neoplasms, Prognosis, Survival Rate
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.